Everolimuspharmacokinetics were unaltered by statins
1. Kovarik JM,Hartmann S, Hubert M, Berthier S, Schneider W, Rosenkranz B, Rordorf C. Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors whencoadministered with everolimus. J Clin Pharmacol (2002) 42, 222–8.